Kamakura, Japan

Yoshifumi Imamura



Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Kamakura, JP (1998 - 2000)
  • Kanagawa, JP (2000 - 2001)

Company Filing History:


Years Active: 1998-2001

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Yoshifumi Imamura

Introduction

Yoshifumi Imamura is a prominent inventor based in Kamakura, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for treating cerebral disorders. With a total of five patents to his name, Imamura's work has garnered attention in both academic and industrial circles.

Latest Patents

One of his latest patents includes the invention of quinolinomorphinane derivatives and their medicinal use. This invention provides a quinolinomorphinan derivative or a pharmacologically acceptable acid addition salt thereof. It also presents an agent for curing or preventing cerebral disorders composed of the derivative and salt, represented by a specific formula. Another notable patent involves indolomorphinan derivatives and their application in curing and preventing cerebral conditions.

Career Highlights

Yoshifumi Imamura is currently employed at Toray Industries, Inc., where he continues to innovate and develop new medicinal compounds. His work at this esteemed company has allowed him to collaborate with other talented researchers and contribute to advancements in healthcare.

Collaborations

Some of his notable coworkers include Hiroshi Nagase and Susumu Matsuda. Their collaborative efforts have further enhanced the research and development of new therapeutic agents.

Conclusion

Yoshifumi Imamura's contributions to medicinal chemistry and his innovative patents highlight his role as a key figure in the field. His ongoing work promises to lead to significant advancements in the treatment of cerebral disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…